---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-139506"
form_type: "8-K"
ticker: "AKBA"
cik: "0001517022"
company_name: "Akebia Therapeutics, Inc."
filed_at: "2023-05-09T23:59:59+00:00"
generated_at: "2026-06-15T08:58:33.300578+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Akebia receives Nasdaq delisting notice for bid price non-compliance; plans appeal

## Summary
- Notified May 9, 2023 for failing minimum bid price (Rule 5550(a)(2)) after second 180-day grace period expired May 8, 2023.
- Company will request a hearing before Nasdaq Hearings Panel, which stays delisting pending panel decision.
- If delisted, expects common stock to be eligible for trading on OTC Markets platform.
- Previous grace periods granted May 2022 and Nov 2022; company did not regain compliance by May 8, 2023.

## SEC filing metadata
- accession: 0001193125-23-139506
- form_type: 8-K
- ticker: AKBA
- cik: 0001517022
- company_name: Akebia Therapeutics, Inc.
- filed_at: 2023-05-09T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517022/000119312523139506/0001193125-23-139506-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517022/000119312523139506/d471133d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-139506
- JSON: https://secwatch.observer/filing/0001193125-23-139506.json
- Plain text: https://secwatch.observer/filing/0001193125-23-139506.txt

## Key facts
- Listing & Compliance Notices
  Akebia Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: May 9, 2023, Akebia Therapeutics, Inc. (the “Company”) was notified by the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the Company’s non-compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Rule”) as of May 8, 2023, the Company’s securities were subject to delisting unless the Company timely appeals the Staff’s determination by requesting a hearing before the Nasdaq Hearings Panel (the “Panel”). The Company plans to timely request a hearing before the Panel, which request will stay any
  evidence_url: https://www.sec.gov/Archives/edgar/data/1517022/000119312523139506/0001193125-23-139506-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.